Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

Thanks for Reading! Real Money Pro($)

Good to sit in for Doug Kass today on the Daily Diary to start the week. It was kind of a 'blah" day of trading with the exceptions of the energy and biotech sectors both of which were down significantly in trading. Oil dropped some 4% on concerns of new supply and potentially weakening demand if trade tensions result in slowing global growth.
A very quiet day in the stock market. Indices remain mixed and have traded in a very narrow range throughout the day. Seems like a lot of traders are already on summer vacation and commentary here on the Daily Diary points also to seeing lower volume than normal.
Beazer Homes, Great Lakes Dredge & Dock and Entercom Communications seem like bargains right now.
Not much movement in the markets so far today as the trading week begins. Major indices are in a narrow range and have fluctuated between slight losses and negligible gains throughout this morning.
Markets open up flat. Biotech is weak today and is down almost 1% in early trading. No major transactions to report as another 'Merger Monday' fails to live up to billing. Arconic (ARNC) is active today. The company announced a deal with Boeing (BA) this morning to supply aluminum sheet and plate for all models produced by Boeing Commercial Airplanes. Jefferies also ups the name to a "Buy" citing that PE firms might be circling the company.

Looking Over BAC Results Real Money Pro($)

Bank of America (BAC) gets things started as far as second quarter earnings reports this week. The banking giant beats on the top and bottom line consensus and the shares are up modestly in pre-market. A couple of tidbits that caught my attention in the bank's report: Merrill Lynch brokerage assets were up 20% Y/Y. The company also states its adding $500 million to its technology spend, citing the benefits of tax reform. Passage of that legislation should continue to bolster the economy, but unfortunately will be offset at least somewhat from the impacts of new tariffs and fallout/retaliation if trade tensions continue to escalate.

Here We Go With Q2 Real Money Pro($)

It is good to sit in for Doug Kass to start the new trading week. Hopefully, equities can continue their rally from last week that saw the S&P 500 gain 1.5% and the NASDAQ rise 1.8%. Reversing a recent trend, small caps significantly underperformed the overall market with the Russell 2000 posting a slight loss.
Focusing on domestically oriented small-caps and keeping more powder dry are two of my strategies.
Adamis Pharmaceuticals and Pieris Pharmaceuticals are names to watch.
FireEye, Achaogen, Hologic and LGI Homes present attractive values in a challenging market.

Columnist Conversations

Texas Instruments (TXN) announced after the close that CEO Brian Crutcher resigned due to violations of the c...
The initial upside target off the recent low comes in around the 333.51-337.71 area. Here is the updated ch...
A cup/handle is one of the strongest and most precise chart patterns out there, proven more often than not.&nb...
Today is 12 days up from the 6/28 low which is very similar to prior rallies of 11-13 days up.  This is r...

BEST IDEAS

News Breaks

Powered by

COLUMNIST TWEETS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.